PDK4 expression was also lower in primary prostate tumors of higher Gleason grade (>7; Fig. 4D), and low PDK4 expression in primary tumors was associated with a shorter recurrence-free survival of patients (Fig. 4E). The gene discussed is PDK4; the disease is prostate neoplasm.